NCT00102076

Brief Summary

One of the principal safeguards mandated by the Federal Regulations governing clinical research with children is the assent requirement: children who are capable must provide an affirmative agreement to participate unless the research "holds out a prospect of direct benefit that is important to the health or well-being of the children and is available only in the context of the research" (46.408). Despite the importance of the assent requirement, the Federal regulations offer no guidelines on its implementation. In the present study, we propose to survey children and one of their parents in order to obtain information concerning children's role in making decisions concerning their participation in clinical research. Five elements of children's involvement in the decision-making process with respect to their participation in clinical research will be assessed: 1) receipt of information concerning the available options; 2) understanding of this information; 3) assessment of the available options; 4) expression of a preferred option; and 5) coordination with parental decision-making. Three groups will be enrolled: 1. Minor/Parent pairs where the minor is participating in, or is in follow-up for, a drug treatment research study for cancer 2. Minor/Parent pairs where the minor is participating in, or is in follow-up for, a drug treatment research study for asthma, and 3. Minor/Parent pairs where the minor is receiving on-going clinical care for asthma. Children 7-14 years of age will be enrolled. Total enrollment will be 400 subject pairs, approximately 150 in cancer research, 150 in asthma research and 100 involved in clinical care for asthma, with approximate balance between the sites. Two formalized survey instruments - research/clinical minor, research/clinical parent - will be developed in consultation with Research Triangle Institute (RTI).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
800

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2001

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 16, 2001

Completed
3.2 years until next milestone

First Submitted

Initial submission to the registry

January 19, 2005

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 20, 2005

Completed
1.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 18, 2006

Completed
Last Updated

July 2, 2017

Status Verified

September 18, 2006

First QC Date

January 19, 2005

Last Update Submit

June 30, 2017

Conditions

Keywords

MinimalRiskRegulationsParentsIRBSurgeryAssent Requirement

Eligibility Criteria

Age7 Years - 14 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children in Research Studies:
  • Currently enrolled in an ongoing medical intervention protocol, including follow-up, for cancer or asthma at one of the participating sites.
  • Post initial visit.
  • Enrolled within the previous year.
  • Physically and cognitively able to participate in a 30 minute interview.
  • Ability to understand and speak English.
  • Age 7-14.
  • Parents of Children in Research Studies:
  • Parent of an eligible research child.
  • Physically and cognitively able to participate in a 30 minute interview.
  • Ability to understand and speak English.
  • Children Receiving Clinical Care:
  • Receiving clinical care at a clinic at one of the participating sites for cancer or asthma.
  • Post initial visit.
  • Physically and cognitively able to participate in a 30 minute interview.
  • +6 more criteria

You may not qualify if:

  • Inability to speak English.
  • Inability to understand spoken English.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Institutes of Health Clinical Center (CC)

Bethesda, Maryland, 20892, United States

Location

Study Design

Study Type
observational
Sponsor Type
NIH

Study Record Dates

First Submitted

January 19, 2005

First Posted

January 20, 2005

Study Start

November 16, 2001

Study Completion

September 18, 2006

Last Updated

July 2, 2017

Record last verified: 2006-09-18

Locations